Concepedia

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease

Ian Ford, Anoop Shah, Ruiqi Zhang, David McAllister, Fiona E. Strachan, Muriel Caslake, David E. Newby, Chris J. Packard, Nicholas L. Mills

Journal of the American College of Cardiology · 2016 · 249 citations · 28 references

DOIFull text

Open access

Abstract

Troponin concentration predicts coronary events, is reduced by statin therapy, and change at 1 year is associated with future coronary risk independent of cholesterol lowering. Serial troponin measurements have major potential to assess cardiovascular risk and monitor the impact of therapeutic interventions.

References

28

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein et al. · Circulation · 2013 · 7.1K citations · Full text

, , +8

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · New England Journal of Medicine · 2008 · 6.5K citations · Full text

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

John R. Downs, Michael Clearfield, Stephen E. Weis et al. · JAMA · 1998 · 5.3K citations

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein et al. · Journal of the American College of Cardiology · 2013 · 3.8K citations · Full text

, , +8